date and there is no any event, circumstance or change that has or reasonably likely to have a material adverse effect to SUTG; (2) The Company’s Shareholders’ Meeting approves the Entire Business
compared to the same period last year. Table 1: Sales Revenue by Product Line for the Three Months Period Ended 31 December (YoY) Product Line/ Business Group Consolidated financial statements Change
Summary of operations and the factors that make a significant change Summary of Operations for the Year 2018 Topic Annual Balance Change 2018 2017 2018 VS 2017 (MB) (MB) % Total Revenue 4,237.6 5,397.2
Q3–2020 Balance by Quarter Change Q3–20 Q2–20 Q3–19 Q3–20 VS Q2–20 Q3–20 VS Q3–19 (Million Baht: MB) (MB) % (MB) % Total Revenue 2,241.1 1,187.6 1,798.9 1,053.5 88.7 442.2 24.6 Total Operating Expenses
of useful lives with reference to the Health Study Report from an independent engineering expert and the repair and maintenance of buildings, machinery and equipment. This is considered the Change in
- 2019 Balance by Quarter Change Q1–20 Q4–19 Q1–19 Q1–20 VS Q4–19 Q1–20 VS Q1–19 (Million Baht: MB) (MB) % (MB) % Total Revenue 1,231.7 2,280.7 1,266.5 (1,049.0) (46.0%) (34.8) (2.7%) Total Operating
expect the improvement after the pandemic of COVID-19 ends. Table 1 : Sales Revenue by Product Line for the Three Months ended 31 March (3M YoY) Sales by geography Consolidated financial statements Change
Amount Change Amount Change Q3.2020 Q3.2019 Amount % Q3.2020 Q3.2019 Amount % Revenue from sale – net 399.89 320.12 79.78 24.92% 392.11 319.50 72.60 22.72% Others income 4.70 6.87 -2.18 -31.64% 6.13 5.96
Medical Business Plc., (CMR) amount Baht 910.58 million. comparing at the same period in 2018 representing 9.87% decrease due to Social Security Office reimbursement of 2015 and 2016 amount Baht 175.00